The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation
Abstract Estetrol (E4) is a natural estrogen with a long half‐life produced only by the human fetal liver during pregnancy. The crystal structures of the estrogen receptor α (ERα) ligand‐binding domain bound to 17β‐estradiol (E2) and E4 are very similar, as well as their capacity to activate the two...
Main Authors: | Anne Abot, Coralie Fontaine, Mélissa Buscato, Romain Solinhac, Gilles Flouriot, Aurélie Fabre, Anne Drougard, Shyamala Rajan, Muriel Laine, Alain Milon, Isabelle Muller, Daniel Henrion, Marine Adlanmerini, Marie‐Cécile Valéra, Anne Gompel, Céline Gerard, Christel Péqueux, Mélanie Mestdagt, Isabelle Raymond‐Letron, Claude Knauf, François Ferriere, Philippe Valet, Pierre Gourdy, Benita S Katzenellenbogen, John A Katzenellenbogen, Françoise Lenfant, Geoffrey L Greene, Jean‐Michel Foidart, Jean‐François Arnal |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2014-10-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201404112 |
Similar Items
-
Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment
by: Anne Gallez, et al.
Published: (2023-06-01) -
Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
by: Anne Gallez, et al.
Published: (2021-05-01) -
The benefits of estetrol addition to drospirenone for contraception
by: Jean Michel Foidart, PhD, MD, et al.
Published: (2023-11-01) -
Neuroprotective effects of estetrol in combined oral contraceptives: A review
by: Mekan R. Orazov, et al.
Published: (2023-07-01) -
An insight into the use of estetrol-drospirenone as effective oral contraceptive
by: Himanshu Chaudhry, et al.
Published: (2023-03-01)